Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Knapp

Showing results (81-90 of 540) with videos related to

Pageof 54
Sort By:
Plos One|June 11, 2014
A comparison of protein kinases inhibitor screening methods using both enzymatic activity and binding affinity determinationAmalie Frederikke Rudolf, Tine Skovgaard, Stefan Knapp, et al.
International Journal of Biological Macromolecules|January 29, 2023
Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9): Its therapeutic potential and selective inhibitionMaria Mushtaq Ali, Sehrish Naz, Sajda Ashraf, et al.
Chemical Science|January 23, 2016
Accurate calculation of the absolute free energy of binding for drug moleculesMatteo Aldeghi, Alexander Heifetz, Michael J Bodkin, et al.
The Journal of Organic Chemistry|February 18, 2022
Cascade Synthesis of Kinase-Privileged 3-Aminoindazoles via Intramolecular N-N Bond FormationW Felix Zhu, Andreas Krämer, Stefan Knapp, et al.
Journal of Medicinal Chemistry|May 31, 2002
NMR-Based screening with competition water-ligand observed via gradient spectroscopy experiments: detection of high-affinity ligandsClaudio Dalvit, Marina Fasolini, Maria Flocco, et al.
Haematologica|February 11, 2010
PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancersLaurent Brault, Christelle Gasser, Franz Bracher, et al.
Protein Science : a Publication of the Protein Society|May 5, 2006
The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1Jeyanthy Eswaran, Judit E Debreczeni, Emma Longman, et al.
Nature Reviews. Drug Discovery|August 6, 2021
Trends in kinase drug discovery: targets, indications and inhibitor designMisty M Attwood, Doriano Fabbro, Aleksandr V Sokolov, et al.
Biochemistry|September 24, 2004
The long acidic tail of high mobility group box 1 (HMGB1) protein forms an extended and flexible structure that interacts with specific residues within and between the HMG boxesStefan Knapp, Susanne Müller, Giuseppe Digilio, et al.
The Journal of Biological Chemistry|October 18, 2005
Structure and substrate specificity of the Pim-1 kinaseAlex N Bullock, Judit Debreczeni, Ann L Amos, et al.
Pageof 54

Showing results (81-90 of 540) with videos related to

Sort By:
Pageof 54
Plos One|June 11, 2014
A comparison of protein kinases inhibitor screening methods using both enzymatic activity and binding affinity determinationAmalie Frederikke Rudolf, Tine Skovgaard, Stefan Knapp, et al.
International Journal of Biological Macromolecules|January 29, 2023
Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9): Its therapeutic potential and selective inhibitionMaria Mushtaq Ali, Sehrish Naz, Sajda Ashraf, et al.
Chemical Science|January 23, 2016
Accurate calculation of the absolute free energy of binding for drug moleculesMatteo Aldeghi, Alexander Heifetz, Michael J Bodkin, et al.
The Journal of Organic Chemistry|February 18, 2022
Cascade Synthesis of Kinase-Privileged 3-Aminoindazoles via Intramolecular N-N Bond FormationW Felix Zhu, Andreas Krämer, Stefan Knapp, et al.
Journal of Medicinal Chemistry|May 31, 2002
NMR-Based screening with competition water-ligand observed via gradient spectroscopy experiments: detection of high-affinity ligandsClaudio Dalvit, Marina Fasolini, Maria Flocco, et al.
Haematologica|February 11, 2010
PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancersLaurent Brault, Christelle Gasser, Franz Bracher, et al.
Protein Science : a Publication of the Protein Society|May 5, 2006
The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1Jeyanthy Eswaran, Judit E Debreczeni, Emma Longman, et al.
Nature Reviews. Drug Discovery|August 6, 2021
Trends in kinase drug discovery: targets, indications and inhibitor designMisty M Attwood, Doriano Fabbro, Aleksandr V Sokolov, et al.
Biochemistry|September 24, 2004
The long acidic tail of high mobility group box 1 (HMGB1) protein forms an extended and flexible structure that interacts with specific residues within and between the HMG boxesStefan Knapp, Susanne Müller, Giuseppe Digilio, et al.
The Journal of Biological Chemistry|October 18, 2005
Structure and substrate specificity of the Pim-1 kinaseAlex N Bullock, Judit Debreczeni, Ann L Amos, et al.
Pageof 54